{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:38:59Z","timestamp":1776605939648,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007310","name":"Wuyi University","doi-asserted-by":"publisher","award":["2022WGALH08"],"award-info":[{"award-number":["2022WGALH08"]}],"id":[{"id":"10.13039\/501100007310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2025ZDZX4070"],"award-info":[{"award-number":["2025ZDZX4070"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmcl.2026.130571","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:19:39Z","timestamp":1770311979000},"page":"130571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and anticancer activity of parthenolide-based PROTACs for IKK\u03b2 degradation"],"prefix":"10.1016","volume":"135","author":[{"given":"Zhenxi","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng-Gao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130571_bb0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1074-5521(01)00049-7","article-title":"The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkappaB kinase","volume":"8","author":"Kwok","year":"2001","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2026.130571_bb0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/C9NP00049F","article-title":"Advances in chemistry and bioactivity of parthenolide","volume":"37","author":"Freund","year":"2020","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmcl.2026.130571_bb0015","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.2174\/0929867326666190816230121","article-title":"Parthenolide and its analogues: a new potential strategy for the treatment of triple-negative breast Tumors","volume":"27","author":"Ara\u00fajo","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2026.130571_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1534686","article-title":"Parthenolide: pioneering new frontiers in hematological malignancies","volume":"16","author":"Zarei","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130571_bb0025","article-title":"Trends in parthenolide research over the past two decades: a bibliometric analysis","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bmcl.2026.130571_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2026.130571_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.692574","article-title":"PROTAC: an effective targeted protein degradation strategy for Cancer therapy","volume":"12","author":"Qi","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130571_bb0040","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1039\/D2CS00220E","article-title":"Chemistries of bifunctional PROTAC degraders","volume":"51","author":"Cao","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2026.130571_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104376","article-title":"PROTAC 2.0: expanding the frontiers of targeted protein degradation","volume":"30","author":"Cornu","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2026.130571_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cbf.3369","article-title":"The PROTAC technology in drug development","volume":"37","author":"Zou","year":"2019","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.bmcl.2026.130571_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmcl.2026.130571_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2026.130571_bb0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","article-title":"Proteolysis targeting chimeras (PROTACs) in \u201cbeyond rule-of-five\u201d chemical space: recent progress and future challenges","volume":"29","author":"Edmondson","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130571_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/cells7090115","article-title":"Targeting IKK\u03b2 in Cancer: challenges and opportunities for the therapeutic utilisation of IKK\u03b2 inhibitors","volume":"7","author":"Prescott","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2026.130571_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114822","article-title":"The role of NF-\u03baB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy","volume":"163","author":"Pavitra","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"10.1016\/j.bmcl.2026.130571_bb0080","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.3390\/cancers14215215","article-title":"Inhibition of I\u03baB kinase is a potential therapeutic strategy to circumvent resistance to epidermal growth factor receptor inhibition in triple-negative breast Cancer cells","volume":"14","author":"Yi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130571_bb0085","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1038\/s41467-025-62717-7","article-title":"Data-driven organic solubility prediction at the limit of aleatoric uncertainty","volume":"16","author":"Attia","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2026.130571_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-981-15-1025-0_19","article-title":"Targeting Cullin-RING ubiquitin ligases and the applications in PROTACs","volume":"1217","author":"Gong","year":"2020","journal-title":"Adv Exp Med Biol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:47:12Z","timestamp":1776602832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"alternative-id":["S0960894X26000387"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130571","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and anticancer activity of parthenolide-based PROTACs for IKK\u03b2 degradation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130571"}}